Spotlight
Video

Ibrutinib & Rituximab is a new standard for WM Design trials that use the combination as a backbone

Loading........
Description: Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains Ibrutinib & Rituximab is a new standard for WM Design trials that use the combination as a backbone at Annual Meeting 2018
Shared By : Annual-Meeting
Posted on : 06/04/18
Added : 1 year ago
Category : News



Recommended

Nothing found.